Results 111 to 120 of about 167,114,309 (280)
Palliative and End of Life Care in Nursing
, 2014 With the number of people requiring palliative and end-of-life care set to increase by 2020, it is the responsibility of every nurse, regardless of specialism, to know how to provide high-quality care to this group of people. Yet caring for those nearing
Nicol, Jane, Nyatanga, Brian
core
McGill Journal of MedicineMcGill Journal of Medicine (MJM) Podcast Series, MJM MedTalks, interviews members of the medical and health sciences community from McGill, and beyond to gain insights into their careers, research, advocacy, and more.
Maryia Samuel +7 more
doaj
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
Molecular Oncology, EarlyView.This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
End-of-Life Issues in the Era of the COVID-19 Pandemic. [PDF]
Hanguk Hosupisu Wanhwa Uiryo Hakhoe Chi, 2020 Ghosh D, Gupta B.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
I think Plato Was Ill: The Cinema and Philosophy in End-of-life Issues
Revista de Medicina y Cine / Journal of Medicine and Movies, 2008 Marie de Hennezel, who introduced palliative care into France, referred to the end-of-life as a strong time; the time of final exchanges, of the last words.
Antonio Lastra
doaj
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
Molecular Oncology, EarlyView.IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
Valuing qalys at the end of life [PDF]
There have been changes in the way that NICE evaluates medical treatments for patients who are in the last stages of their lives. If medicines fulfil some criteria to be considered “end of life” NICE considers if QALYs gained under these circumstances ...
Belen Corbacho +2 more
core